BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36926504)

  • 1. Identifying barriers and facilitators for implementing harm reduction strategies for methamphetamine use into hospital settings.
    Forchuk C; Serrato J; Scott L
    Front Health Serv; 2023; 3():1113891. PubMed ID: 36926504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for sharps boxes to be offered in the hospital setting for people who use substances: Removing sharps boxes puts all of us at risk.
    Forchuk C; Silverman M; Rudnick A; Serrato J; Schmitt B; Scott L
    Front Health Serv; 2023; 3():1113163. PubMed ID: 37089452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "No Good Choice": What are the Issues of Having no Harm Reduction Strategies in Hospitals?
    Forchuk C; Serrato J; Scott L; Rudnick A; Dickey C; Silverman M
    Subst Abuse; 2023; 17():11782218231186065. PubMed ID: 37476501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of stigma among people with lived experience of methamphetamine use within the hospital setting: qualitative point-in-time interviews and thematic analyses of experiences.
    Forchuk C; Serrato J; Scott L
    Front Public Health; 2024; 12():1279477. PubMed ID: 38414902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
    Eddy K; Jordan Z; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators.
    Harvey LH; Sliwinski SK; Flike K; Boudreau J; Gifford AL; Branch-Elliman W; Hyde J
    J Addict Dis; 2023 May; ():1-9. PubMed ID: 37154222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings.
    Lindenfeld Z; Hagan H; Chang JE
    J Gen Intern Med; 2023 Nov; 38(15):3273-3282. PubMed ID: 37227658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.
    Khan GK; Harvey L; Johnson S; Long P; Kimmel S; Pierre C; Drainoni ML
    Harm Reduct J; 2022 Apr; 19(1):35. PubMed ID: 35414072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: A qualitative study of midwives' experience.
    Oni HT; Buultjens M; Blandthorn J; Davis D; Abdel-Latif M; Islam MM
    Midwifery; 2020 Feb; 81():102595. PubMed ID: 31838337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Chiropractic Services in the Canadian Forces Health Services - Perceptions of Facilitators and Barriers Among Key Informants.
    Mior SA; Vogel E; Sutton D; French S; Côté P; Nordin M; Loisel P; Laporte A
    Mil Med; 2019 May; 184(5-6):e344-e351. PubMed ID: 30462275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers of change toward an elder-friendly surgical environment: perspectives of clinician stakeholder groups.
    Hanson HM; Warkentin L; Wilson R; Sandhu N; Slaughter SE; Khadaroo RG
    BMC Health Serv Res; 2017 Aug; 17(1):596. PubMed ID: 28836979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital.
    Hyshka E; Morris H; Anderson-Baron J; Nixon L; Dong K; Salvalaggio G
    Drug Alcohol Depend; 2019 Nov; 204():107523. PubMed ID: 31541875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators, barriers and potential solutions to the integration of depression and non-communicable diseases (NCDs) care in Malawi: a qualitative study with service providers.
    Zimba CC; Akiba CF; Matewere M; Thom A; Udedi M; Masiye JK; Kulisewa K; Go VF; Hosseinipour MC; Gaynes BN; Pence BW
    Int J Ment Health Syst; 2021 Jun; 15(1):59. PubMed ID: 34116699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers, facilitators and views about next steps to implementing supports for evidence-informed decision-making in health systems: a qualitative study.
    Ellen ME; Léon G; Bouchard G; Ouimet M; Grimshaw JM; Lavis JN
    Implement Sci; 2014 Dec; 9():179. PubMed ID: 25476735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure Injury Prevention in a Saudi Arabian Intensive Care Unit: Registered Nurse Attitudes Toward Prevention Strategies and Perceived Facilitators and Barriers to Evidence Implementation.
    Tayyib N; Coyer F; Lewis P
    J Wound Ostomy Continence Nurs; 2016; 43(4):369-74. PubMed ID: 27391288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to and facilitators for implementing quality improvements in palliative care - results from a qualitative interview study in Norway.
    Sommerbakk R; Haugen DF; Tjora A; Kaasa S; Hjermstad MJ
    BMC Palliat Care; 2016 Jul; 15():61. PubMed ID: 27422410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
    Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
    JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.